NEWS
![ニュース画像](https://revascularbio.com/wp-content/themes/revascular-bio/assets/img/home/news_img.png)
NEWS
2023.11.10
Fundraising
Revascular Bio has received an investment of 220 million JPY from Osaka University Venture Capital Co., Ltd. Based on the funds raised this time, we will establish a method for preparing vascular endothelial stem cells and transfer the technology to a cell culture processing facility to realize cell therapy for intractable skin ulcers.
Read More Here: https://blog.ouvc.co.jp/en/topics/231110-0